Is the case of any of (II) the following (I), or a pharmaceutically acceptable salt thereof, or a compound represented by the following general formula [1] (I) X: CH, N R 1: halogen R 2: H, halogen, CN, [2], [3], [8], [9], - O- alkyl, -O- saturated ring, [2]: - C (R C) (R D {: H, alkyl, etc. R C-E} (R E))[3]: - N (R F) (R G) {R F-G: H, OH, amino, (hetero) aryl, etc.} {: Alkyl, OH, alkoxy, amino, etc. R L} (= O) R L C -: [8] > C-C (= O) R B {R B :( substituted) amino, alkoxy, OH, etc.}: (II) X [9] :( substituted) phenyl R 1: halogen R 2: H R 3: H, OH R 4-5: H, alkyl次の(I)又は(II)のいずれかの場合である、次の一般式[1]で表される化合物又はその医薬上許容される塩(I)X:CH,N;R1:ハロゲン;R2:H,ハロゲン,CN,[2],[3],[8],[9],-O-アルキル,-O-飽和環 等[2]:-C(RC)(RD)(RE){RC-E:H,アルキル 等}[3]:-N(RF)(RG){RF-G:H,OH,アミノ,(ヘテロ)アリール 等}[8]:-C(=O)RL{RL:アルキル,OH,アルコキシ,アミノ 等}[9]:(置換)フェニル(II)X:>C-C(=O)RB{RB:(置換)アミノ,アルコキシ,OH等}R1:ハロゲン;R2:H;R3:H,OH;R4-5:H,アルキル
